Clinical Trials
32 trialsPRISM
Dana-Farber Cancer Institute
PALANGI3
Centre Oscar Lambret
CRYODESMO01
University Hospital, Strasbourg, France
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
National Institutes of Health Clinical Center (CC)
Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
PROSa Desmoid
Technische Universität Dresden
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Ohio State University
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
DeFi
SpringWorks Therapeutics, Inc.
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Children's National Research Institute
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
Yonsei University
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
National Institutes of Health Clinical Center (CC)
CT-guided Radioactive Iodine-125 Seed Implantation for Recurrent Desmoid Tumors
Peking University Third Hospital
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
Children's Oncology Group
QUALIFIED
Erasmus Medical Center
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
MaineHealth
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
National Cancer Institute (NCI)
Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059
Iterion Therapeutics
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
Rabin Medical Center
Optional Sub-study to Intraoperative Imaging With ICG Registry
Abramson Cancer Center at Penn Medicine
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Children's Oncology Group
Study to Evaluate Imatinib in Desmoid Tumors
Heidelberg University
Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
UNICANCER
Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas
Children's Oncology Group
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Children's Oncology Group
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Radiation Therapy in Treating Patients With Aggressive Fibromatoses
European Organisation for Research and Treatment of Cancer - EORTC
Toremifene in Treating Patients With Desmoid Tumors
National Cancer Institute (NCI)
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
National Institutes of Health Clinical Center (CC)
A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome
Triemli Hospital